Launch of new OYSTA website

We are happy that we have launched a new web page for OYSTA – an innovative healthcare brand which we have developed together with our partner OnDosis.
With OYSTA, we aim to revolutionize the way how patients take their medicines by combining pharmaceuticals with e-health technology to enable intuitive, precise, and flexible dosing. It is  a novel treatment approaches for attention deficit hyperactivity disorder (ADHD).

The new web page provides an overview of the purpose, function, and value of the unique product concept. For our community we have already recorded a sneak peek, but see for yourself and learn more about OYSTA.

For more information about OYSTA and innovative healthcare pharmaceuticals with e-health technology, please send an email to or visit:

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at or visit us on: